13F
中

CON CONCENTRA GROUP HOLDINGS PAR

2026Q1 · CUSIP 20603L102 · Sector: Healthcare & Biotech

Lit · Institutions accelerating in
Holders
277
Δ holders QoQ
+17
Breadth percentile
Top 18%
Whale holders
140
Δ whales
+7
Inst. holding value
$2.2B
New positions
50
Closed positions
33
Price momentum (1Q)
+10.5%
Put / Call
0/0

Breadth history (34 quarters)

2024Q4: Δ+154 · h=233 2025Q1: Δ+23 · h=256 2025Q2: Δ-2 · h=254 2025Q3: Δ-4 · h=250 2025Q4: Δ+10 · h=260 2026Q1: Δ+17 · h=277 2024Q4: holders=233 2025Q1: holders=256 2025Q2: holders=254 2025Q3: holders=250 2025Q4: holders=260 2026Q1: holders=277 -154 -77 +0 +77 +154 209250291 24Q425Q125Q225Q325Q426Q1 Δ holders (bar) Holders (line)

Past Lit Events & Aftermath 3 lit events

Period Percentile Next-1Q return Next-2Q return
2026Q1 Top 18% — —
2025Q1 Top 9% +2.1% -14.2%
2024Q4 Top 2% -2.8% -0.7%

Options Sentiment

Put holders
0
QoQ: 0
Call holders
0
QoQ: 0

See methodology →

Fundamentals

PE (TTM)
22.2
EPS (TTM)
$1.39
EPS YoY
+7.8%
Revenue (TTM)
$2.2B
Revenue YoY
+15.5%
Quarterly Revenue & EPS (4Y)
2023-06-30: $467M 2023-09-30: $474M 2024-03-31: $468M 2024-06-30: $478M 2024-09-30: $490M 2024-12-31: $465M 2025-03-31: $501M 2025-06-30: $551M 2025-09-30: $573M 2025-12-31: $539M 2026-03-31: $570M 2023-06-30: EPS 0.51 2023-09-30: EPS 0.51 2024-03-31: EPS 0.47 2024-06-30: EPS 0.50 2024-09-30: EPS 0.37 2024-12-31: EPS 0.12 2025-03-31: EPS 0.30 2025-06-30: EPS 0.35 2025-09-30: EPS 0.38 2025-12-31: EPS 0.27 2026-03-31: EPS 0.39 0M 286M 573M $M 0.00 0.28 0.56 2023202420252026 Revenue EPS

Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable

P/E (TTM) over time
4Y median 17 2024-06-30: PE 11.52024-09-30: PE 10.92024-12-31: PE 15.32025-03-31: PE 17.42025-06-30: PE 20.22025-09-30: PE 16.72025-12-31: PE 182026-03-31: PE 18.6 10 16 21 2023202420252026

P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden

As of 2026-03-31 · SEC filings (XBRL)